In such a way, glioma cells expressing miR-182 promote glioma-initiating cell (GIC) differentiation and diminish cancer cell proliferation by downregulating the caspase and p53 inhibitor, Bcl2L12, c-Met, and HIF2A [160]. Here, MET is linked to central nervous system cancer.